Copyright
        ©The Author(s) 2015.
    
    
        World J Hepatol. Jun 28, 2015; 7(12): 1679-1684
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1679
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1679
            Table 1 The definitions of the metabolic syndrome
        
    | NCEP ATP III | IDF | |
| Absolutely required | None | Central obesity (waist circumference) ≥ 94 cm in males or ≥ 80 cm in females European origin ≥ 90 cm in males or ≥ 80 cm in females | 
| Criteria | Any three of the five criteria below | Central obesity plus two of the four criteria below | 
| Obesity | (1) waist circumference > 40 inches in males, or > 35 inches in females | |
| Hyperglycemia | (2) fasting glucose ≥ 100 mg/dL or treated for DM | (1) fasting glucose ≥ 100 mg/dL | 
| Dyslipidemia | (3) TG ≥ 150 mg/dL or treated for dyslipidemia | (2) TG ≥ 150 mg/dL or treated for dyslipidemia | 
| Or (4) HDL cholesterol < 40 mg/dL in males, or < 50 mg/dL in females or under treatment | Or (3) HDL cholesterol < 40 mg/dL in males, or < 50 mg/dL in females or under treatment | |
| Hypertension | (5) > 130 mmHg systolic or > 85 mmHg diastolic or treated for HTN | (4) > 130 mmHg systolic or > 85 mmHg diastolic or treated for HTN | 
- Citation: Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(12): 1679-1684
 - URL: https://www.wjgnet.com/1948-5182/full/v7/i12/1679.htm
 - DOI: https://dx.doi.org/10.4254/wjh.v7.i12.1679
 
